There are still many diseases that cannot be cured by current medicine or surgery, even though the recent advance in medicine by the great gift of the wisdom and efforts of our predecessors.

We would like to contribute to the health and welfare of people suffering from these diseases all over the world by using innovative regenerative medicines and cell therapies that do not exist today.

Since my background is ophthalmology, I am currently working on the development of iPS cell based new regenerative medicine product for the corneal endothelial diseases.

Keratoplasty (corneal transplantation) is still not widely available around the world.

Therefore, we pursue the goal to produce corneal endothelial cell substitute cells from iPS cells and to provide patients all over the world with a beneficial treatment.